表紙
市場調查報告書

全球糖尿病診斷市場

Diabetes Diagnostics

出版商 Global Industry Analysts, Inc. 商品編碼 240186
出版日期 內容資訊 英文 609 Pages
商品交期: 最快1-2個工作天內
價格
全球糖尿病診斷市場 Diabetes Diagnostics
出版日期: 2020年09月01日內容資訊: 英文 609 Pages
簡介

本報告提供全球糖尿病診斷市場相關調查,彙整市場現狀與今後的成長預測,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 產業概要

  • 更輕鬆,更經濟,更有效的管理
  • 有主要特徵的糖尿病檢驗發展
  • 促進成長要素
  • 全球糖尿病發病率的驚人水平推動了對糖尿病診斷設備的需求
  • 糖尿病成為死亡的主要原因之一
  • 未來預測有利
  • 已開發國家是主要收益貢獻國
  • 發展中國家持續提供莫大成長機會
  • 發展中國家的糖尿病診斷設備銷售額促進要素
  • 穩定的經濟方案

第3章 市場趨勢,促進要素,課題

第4章 產品概要

  • 序論
  • 持續的血糖監測系統
  • 血紅素A1c檢驗
  • 血糖檢查裝置
  • 糖尿病檢驗設備
  • 糖尿病:慢性的疾病
  • 症狀
  • 種類

第5章 競爭環境

  • 大型製藥公司壟斷市場
  • 本地製藥公司的競爭強化地區市場
  • 持續的血糖監測系統市場
  • Medtronic壟斷全球CGM設備市場
  • 血糖監測系統市場
  • 低價優質產品 其他

第6章 全球市場預測

第7章 各地區市場趨勢

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

第8章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-3404

Diabetes is the Largest Epidemic in Human History Surpassing Even the Black Death of the 14th Century. Diabetes Diagnostics to Reach a Colossal $45.6Billion

The global market for Diabetes Diagnostics is projected to reach US$45.6billion by the year 2027, trailing a post COVID-19 CAGR of 8.1% over the analysis period 2020 through 2027. Wiping out over 20% of the world's population in the 14th century, "Black Death" was the most devastating pandemics in human history. Today type 2 diabetes is gradually emerging into an epidemic much bigger than Black Death. The disease will continue to grow driven by the growing incidence of diabetes in parallel to obesity and the ensuing rise of "diabesity" as a global epidemic; improper lifestyle patterns and the resulting increase in risk factors even among non-obese population. The diagnosis and treatment of diabetes have always been challenging for both the healthcare providers and the patients. Keeping up with regular exercises, diabetic meal plans, medications, and check on blood sugar levels are never easy. Diabetic patients need continuous self-management on a regular basis. It is also a tedious task for the doctors to analyze blood sugar fluctuations and other factors involved in diabetes care. Further in developing economies, managing diabetes and the complications associated with it is a big challenge due to issues such as lack of healthcare professionals, limited access to healthcare facilities, lack of awareness among people and lack of information that enables therapeutic decision-making.

All these problems contribute to missed diagnosis and delayed visits to the clinics. However, technological advancements are anticipated to solve these problems to a great extent. Advancements in the food and information technologies have revolutionized the diagnosis and treatment of diabetes. Amid the ongoing COVID-19 situation, technology seems to be provided with a chance to prove its worth more than ever before. With the latest technologies in healthcare sector such as food trackers, health apps, glucometers and pedometers, tracking of data has become easy to manage. Technology is expected to bring latest developments particularly during the COVID-19 times, where social distancing is the new norm. Introduction of glucometers, EMRs, mobile apps and digital clinics has made data tracking and lifestyle change much easier. Other technologies such as social media educate and motivate the diabetic patients to bring a change in their lifestyle. The market especially stands to benefit from the rapid advances being made in the field of continuous glucose monitoring such as smart predictive algorithms for automated control; growing understanding of diabetes pathophysiology and the resulting development of more potent disease prevention, control and management strategies; focus on diabetes self-management and research interest in the development of diabetes tracking wearable devices; growing revenue opportunity for mHealth solutions for diabetes diagnosis; launch of implantable continuous glucose monitor and cloud-enabled CGM devices; rising popularity of near patient testing and the resulting demand for HbA1c devices and encouraging research breakthroughs in "artificial pancreas".

Another worrisome trend positively influencing growth in the market is the increasing incidence of diabetes in children and the resulting focus on shed on timely screening, diagnosis and therapy administration among pediatric patients. Mainstream adoption universal screening for gestational diabetes mellitus (GDM) will also drive revenue opportunities in the market. Asia-Pacific ranks as the fastest growing market led by grim risk population analysis attributable to rapid urbanization, growing affluence and nutrition transition, less physically demanding lifestyles, high prevalence of smoking, alcohol abuse, heavy consumption of refined carbohydrates, lack of exercise and over nutrition. India and China represent the epicenter of the diabetes epidemic with both the countries recording the highest number of diabetics in the region. For long, genes, lifestyle & behavioral change have been in the spotlight as risk factors for developing type 2 diabetes. Currently, epigenetic changes are emerging to be forefront as a possible reason for the rising incidence of type 2 diabetes. While treatment regimes are evolving, routine testing has and will continue to remain vital in effective diabetes management. There is an acute need for easy-to-use, efficient, accurate and affordable solutions for effective management of the disease; and technology innovation and development of non-invasive techniques to simplify regular glucose testing. The most popular home diagnostic device is the blood glucose monitor that assists in detecting the amount of glucose present in blood. A special coated strip containing blood sample is inserted into the machine, which consequently yields results on a digital display. Certain blood glucose monitors are also equipped with a memory component capable of holding multiple test results. Analog glucose monitors are traditional blood glucose meters that uses a blood sample drawn from pricking a patient's finger.

Competitors identified in this market include, among others,

  • A.Menarini Diagnostics Ltd.
  • Abbott Diabetes Care Inc.
  • Acon Laboratories Inc.
  • AgaMatrix Inc.
  • Apex Biotechnology Corporation
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • BIONIME Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DexCom Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • HemoCue® AB
  • LifeScan, Inc.
  • Medtronic PLC
  • Nova Biomedical Corporation
  • OSANG Healthcare Co. Ltd.
  • PTS Diagnostics
  • Sanofi S.A.
  • Sanwa Kagaku Kenkyusho Co Ltd.
  • Siemens Healthineers
  • Sinocare Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Tosoh Bioscience Inc.
  • Trinity Biotech plc
  • Trividia Health Inc.
  • Ypsomed AG

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 and a Looming Global Recession
    • Technologies Come to the Aid for Diabetes Diagnosis, Monitoring and Management
    • Diabetes: A Chronic Body Disorder
    • An Introduction to Diabetes Diagnostics
    • Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
    • Developed Regions Lead, Developing Economies to Spearhead Future Growth
    • Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
    • Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
    • EXHIBIT 1: World Diabetes and Population Statistics (2019, 2030 & 2045)
    • EXHIBIT 2: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
    • EXHIBIT 3: World Diabetes Prevalence (2000-2019)
    • EXHIBIT 4: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2019 and 2045
    • EXHIBIT 5: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • Diabetes Emerges as One of the Leading Causes of Mortality
    • EXHIBIT 6: Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
    • Competition
    • EXHIBIT 7: Global Continuous Glucose Monitoring Market Breakdown (in %) by Leading Competitors for 2019
    • EXHIBIT 8: Global Blood Glucose Monitoring Devices Market Share (in %) by Company for 2019
    • Quality Products at Low Prices: Mantra for Success in the Marketplace
    • SMBG Makers Turn to Mobile Devices to Woo Users on the Move
    • World Brands
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
    • EXHIBIT 9: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 10: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
    • EXHIBIT 11: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
    • EXHIBIT 12: Diabetes-Related Health Expenditure: Average Spending Per Person (in US$) by Region for 2010 and 2019
    • Increasing Obesity Levels Underpins Market Growth
    • EXHIBIT 13: Average Per Capita Annual Health Expenditure (In US$) due to Obesity
    • EXHIBIT 14: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market
    • EXHIBIT 15: Global Continuous Glucose Monitoring Systems Market by Component for 2020E
    • EXHIBIT 16: Global Continuous Glucose Monitoring Systems Market by End-Use (in %) for 2020E
    • CGM Demand Benefits from the COVID-19 Pandemic
    • CGM Market Breaks through Barriers to Witness Growing Adoption
    • Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes
    • Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
    • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
    • Glycated Albumin: A Potential Threat to HbA1c
    • Role of HbA1c Testing in Diabetes Diagnosis and Management
    • HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
    • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
    • Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth
    • Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
    • Blood Sugar Lancets Market: Sustained Growth in Demand
    • Self-Monitoring/Household Blood Glucose Sustains Market Growth
    • Rising Smartphone Penetration Augurs Well for SMBG Market
    • EXHIBIT 17: Smartphone Penetration Rate as Share of Total Population: 2016-2020
    • Barriers to Adoption of New Technology in BGM Products
    • Accuracy Issues Plague Blood Glucose Meters Market
    • Insulin Pens Rise in Popularity for Administering Insulin
    • Smart Insulin Pens
    • Increasing Role of Self-Injection Devices in Diabetes Management
    • Prefilled Syringe Pen Injectors
    • Human Factors Influence the Design of Self Injection Systems
    • Pain Free Shots: A Growing R&D Domain
    • Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market
    • EXHIBIT 18: Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
    • EXHIBIT 19: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
    • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
    • Innovations & Product Advancements: Prime Focus Area for Vendors
    • Focus on Development of Wearable Devices
    • An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques
    • Companies Develop Innovative Needle-Free Alternatives
    • mHealth Solutions for Diabetes Diagnosis
    • Non-invasive Wearable Glucose Testing Devices
    • Innovations in Insulin Pumps
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Test Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Analog Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Continuous Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 29: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 32: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 35: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US
    • EXHIBIT 20: Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
    • EXHIBIT 21: Diabetes Prevalence by Ethnicity: 2019
    • Aging Demographics: A Factor Driving Diabetes Prevalence
    • EXHIBIT 22: Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
    • EXHIBIT 23: North American Aging Population (in Thousands) by Age Group: 1975-2050
    • EXHIBIT 24: Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019
    • Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices
    • Regulatory Guidance for Glucose Meter Companies
    • Insulin Syringes Dominate the Insulin Delivery Devices Market
    • Emerging Grey Market for Testing Strips
    • Competition
    • Companies Focus on Research for Better Diabetes Diagnostics
    • Market Analytics
    • TABLE 40: USA Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: USA Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: USA 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 43: USA Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: USA Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: USA 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market
    • EXHIBIT 25: Diabetes Statistics in Canada (2019): Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s), and Number of Diabetes-Related Deaths (in '000s)
    • Market Analytics
    • TABLE 46: Canada Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: Canada Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: Canada 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Canada Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: Canada 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • Aging Population Drives Diabetes Diagnostics Market
    • EXHIBIT 26: Diabetes Statistics in Japan (2019): Number of Adults with Diabetes (in '000s), Adults with Undiagnosed Diabetes (in '000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), and Number of Diabetes-Related Deaths (in '000s)
    • Market Analytics
    • TABLE 52: Japan Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Japan Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: Japan 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: Japan Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 57: Japan 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • Increasing Diabetes Incidence Drives Market Growth
    • EXHIBIT 27: Diabetes Statistics in China for 2019
    • Lower Penetration Offers High Growth Potential
    • EXHIBIT 28: Chinese Glucose Meters Breakdown of Revenues by Leading Companies for 2019
    • Market Analytics
    • TABLE 58: China Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: China Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 60: China 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: China Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 63: China 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • Diabetes Diagnostics Market in Europe: A Promising Outlook
    • EXHIBIT 29: Diabetes and Population Statistics in Europe (2019, 2030 & 2045)
    • EXHIBIT 30: Diabetes Statistics in Europe (2019): Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries
    • Reimbursement Scenario
    • Market Analytics
    • TABLE 64: Europe Current & Future Analysis for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 65: Europe Historic Review for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 66: Europe 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 69: Europe 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 72: Europe 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 73: France Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: France Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 75: France 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 76: France Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: France Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 78: France 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 79: Germany Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: Germany Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 81: Germany 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 82: Germany Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: Germany Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 84: Germany 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 85: Italy Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: Italy Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 87: Italy 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 88: Italy Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: Italy Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 90: Italy 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 91: UK Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: UK Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 93: UK 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 94: UK Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: UK Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 96: UK 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 97: Spain Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Spain Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 99: Spain 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 100: Spain Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Spain Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 102: Spain 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 103: Russia Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: Russia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 105: Russia 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 106: Russia Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: Russia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 108: Russia 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 109: Rest of Europe Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: Rest of Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 111: Rest of Europe 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 112: Rest of Europe Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Rest of Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 114: Rest of Europe 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities
    • EXHIBIT 31: Diabetes and Population Statistics in South East Asia (2019 & 2045)
    • EXHIBIT 32: Diabetes and Population Statistics in Western Pacific (2019 & 2045)
    • EXHIBIT 33: Diabetes Statistics in Select Asia-Pacific Countries: Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in '000s) for 2019
    • Public and Private Sector Diabetes Care
    • Market Analytics
    • TABLE 115: Asia-Pacific Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 116: Asia-Pacific Historic Review for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 117: Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 118: Asia-Pacific Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 120: Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 121: Asia-Pacific Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 123: Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 124: Australia Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Australia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 126: Australia 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 127: Australia Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Australia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 129: Australia 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • INDIA
    • Expanding Diabetic Population Spurs Growth in the Indian Market
    • Blood Glucose Monitoring Market: An Overview
    • HbA1c Testing Continues to Gain Momentum
    • Glucose Meters Rely on Imported Technology
    • Market Analytics
    • TABLE 130: India Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: India Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 132: India 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 133: India Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: India Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 135: India 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 136: South Korea Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: South Korea Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 138: South Korea 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 139: South Korea Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 140: South Korea Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 141: South Korea 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 142: Rest of Asia-Pacific Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 143: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 144: Rest of Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 145: Rest of Asia-Pacific Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 146: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 147: Rest of Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America
    • EXHIBIT 34: Diabetes and Population Statistics in South & Central America (2019 & 2045)
    • Market Analytics
    • TABLE 148: Latin America Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 149: Latin America Historic Review for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 150: Latin America 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 151: Latin America Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 152: Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 153: Latin America 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 154: Latin America Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 155: Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 156: Latin America 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 157: Argentina Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 158: Argentina Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 159: Argentina 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 160: Argentina Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 161: Argentina Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 162: Argentina 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 163: Brazil Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 164: Brazil Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 165: Brazil 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 166: Brazil Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 167: Brazil Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 168: Brazil 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 169: Mexico Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 170: Mexico Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 171: Mexico 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 172: Mexico Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 173: Mexico Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 174: Mexico 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 175: Rest of Latin America Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 176: Rest of Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 177: Rest of Latin America 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 178: Rest of Latin America Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 179: Rest of Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 180: Rest of Latin America 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 181: Middle East Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 182: Middle East Historic Review for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 183: Middle East 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 184: Middle East Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 185: Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 186: Middle East 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 187: Middle East Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 188: Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 189: Middle East 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 190: Iran Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 191: Iran Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 192: Iran 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 193: Iran Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 194: Iran Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 195: Iran 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 196: Israel Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 197: Israel Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 198: Israel 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 199: Israel Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 200: Israel Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 201: Israel 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 202: Saudi Arabia Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 203: Saudi Arabia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 204: Saudi Arabia 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 205: Saudi Arabia Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 206: Saudi Arabia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 207: Saudi Arabia 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 208: UAE Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 209: UAE Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 210: UAE 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 211: UAE Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 212: UAE Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 213: UAE 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 214: Rest of Middle East Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 215: Rest of Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 216: Rest of Middle East 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 217: Rest of Middle East Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 218: Rest of Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 219: Rest of Middle East 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 220: Africa Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 221: Africa Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 222: Africa 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2020 & 2027
    • TABLE 223: Africa Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 224: Africa Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 225: Africa 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 91